As of Nov 17
| +0.0115 / +1.70%|
The 3 analysts offering 12-month price forecasts for Biocept Inc have a median target of 2.50, with a high estimate of 3.00 and a low estimate of 1.80. The median estimate represents a +262.53% increase from the last price of 0.69.
The current consensus among 2 polled investment analysts is to Buy stock in Biocept Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.